Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Bhagiradha Chemicals & Industries Ltd (BHAGCHEM)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531719 NSE: BHAGCHEM Pesticides & Agrochemicals | Small Cap | Bhagiradha Chemicals Share Price
₹245.95 1.45 (0.59%)
As on 25-Sep'26 16:59
Bhagiradha Chemicals & Industries Ltd (BHAGCHEM)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531719 NSE: BHAGCHEM Pesticides & Agrochemicals | Small Cap | Bhagiradha Chemicals Share Price
₹245.95 1.45 (0.59%)
As on 25-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹3,189 Cr.
Current Price
₹246
52-Week Low / High
₹170 / 316
TTM EPS
₹2.1
TTM Sales
₹607 Cr.
Book Value per Share
₹54.9
P/E Ratio
115.87
Higher than its 5-year historical median
Industry PE
28.3
Price to Book (P/B)
4.48
Lower than its 5-year historical median
Price to Sales (P/S)
5.25
Higher than its 5-year historical median
EV/EBITDA
41.38
Higher than its 5-year historical median
Dividend Yield
0.06%
Profitability Efficiency
Return on Equity (ROE)
2.63%
Underperforms industry median
Return on Capital Employed (ROCE)
4.55%
Underperforms industry median
Return on Assets (ROA)
1.77%
Operating Profit Margin
10.7%
Net Profit Margin
3.39%
Gross Profit Margin
7.8%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
19.45%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
54.64%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
31.1%
Asset Quality
Promoter Holding
19.60%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹699 Cr.
Equity
₹13 Cr.
Face Value
₹1
All Time Low / High
₹0.35 / 448.00
Check Before You Invest
Quality
Not GoodValuation
Somewhat OvervaluedCheck Valuation charts
Price Trend
Weak
Is Bhagiradha Chemicals & Industries Ltd a good quality company?
Bhagiradha Chemicals & Industries Ltd is a weak quality company, based on a inconsistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Bhagiradha Chemicals & Industries Ltd performance compare with that of its Peers?
Revenue growth of Bhagiradha Chemicals & Industries Ltd vs industry peers?
Bhagiradha Chemicals & Industries Ltd revenue CAGR is 11.01%, compared to the industry median CAGR of 1.96%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Bhagiradha Chemicals & Industries Ltd?
Promoters hold 19.60% of the Bhagiradha Chemicals & Industries Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Bhagiradha Chemicals & Industries Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 33.3% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Bhagiradha Chemicals & Industries Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 8.5% | 0.8% | 22% | 8.3% | 20.7% | 24.8% | 22.1% | 8.7% | 7.5% | 5.2% | - |
| Value Creation Index ⓘ | -0.4 | -0.9 | 0.6 | -0.4 | 0.5 | 0.8 | 0.6 | -0.4 | -0.5 | -0.6 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 203 | 183 | 384 | 246 | 318 | 436 | 502 | 407 | 436 | 521 | 571 |
| Sales YoY Gr. | - | -9.6% | 109.5% | -36% | 29.4% | 37.1% | 15.3% | -19% | 7.3% | 19.5% | - |
| Adj EPS ⓘ | -0 | 0.5 | 1.9 | 0.5 | 2.4 | 3.8 | 4.4 | 1.9 | 1.8 | 2 | 2.2 |
| YoY Gr. | - | NA | 302.1% | -75.7% | 406.4% | 58.8% | 16.9% | -58.1% | -1.6% | 11% | - |
| BVPS (₹) ⓘ | 8.9 | 11.2 | 13.5 | 13.9 | 16.4 | 20.1 | 30.3 | 31.9 | 53.9 | 55.8 | 56.6 |
| Adj Net Profit ⓘ | -0.1 | 4.2 | 18.3 | 4.4 | 22.6 | 35.8 | 46 | 19.3 | 23.6 | 26.2 | 29 |
| Cash Flow from Ops. ⓘ | 7.7 | -26.8 | 48.9 | 48.2 | 3.5 | 6.7 | 12.9 | 38.9 | -1.1 | 35.8 | - |
| Debt/CF from Ops. ⓘ | 8.3 | -2.3 | 1 | 0.9 | 17.6 | 12 | 3.9 | 1.6 | -65.4 | 2.5 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 11.1% | 10.4% | 1.3% | 19.5% | ||||
| Adj EPS ⓘ | NA | -3.2% | -23% | 11% | ||||
| BVPSⓘ | 22.7% | 27.7% | 22.6% | 3.5% | ||||
| Share Price | 33.6% | 33% | 24.9% | -1.4% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | -0.2 | 5.5 | 15.9 | 3.4 | 15.7 | 20.7 | 18.2 | 5.3 | 4.2 | 3.7 | 3.9 |
| Op. Profit Mgn % ⓘ | 5.6 | 6.3 | 10.8 | 6.9 | 14.8 | 15.7 | 15.5 | 10.6 | 8.7 | 9.5 | 10.2 |
| Net Profit Mgn % ⓘ | -0.1 | 2.3 | 4.8 | 1.8 | 7.1 | 8.2 | 9.2 | 4.7 | 5.4 | 5 | 5 |
| Debt to Equity ⓘ | 1.3 | 0.6 | 0.4 | 0.3 | 0.4 | 0.4 | 0.2 | 0.2 | 0.1 | 0.1 | - |
| Working Cap Days ⓘ | 204 | 280 | 149 | 176 | 113 | 124 | 149 | 237 | 391 | 330 | 98 |
| Cash Conv. Cycle ⓘ | 60 | 95 | 46 | 70 | 54 | 65 | 93 | 139 | 136 | 125 | 43 |
Valuation of Bhagiradha Chemicals - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|
| Sales | 246 | 318 | 436 | 502 | 408 | 440 | 536 |
| Operating Expenses ⓘ + | 229 | 271 | 367 | 425 | 365 | 404 | 479 |
| Operating Profit ⓘ | 17 | 47 | 68 | 77 | 43 | 37 | 57 |
| Operating Profit Margin (%) | 6.9% | 14.7% | 15.7% | 15.4% | 10.5% | 8.4% | 10.7% |
| Other Income ⓘ + | 2 | 1 | 1 | 1 | 3 | 9 | 2 |
| Interest ⓘ | 5 | 8 | 9 | 5 | 8 | 7 | 17 |
| Depreciation ⓘ | 7 | 8 | 9 | 10 | 11 | 14 | 21 |
| Profit Before Tax ⓘ | 9 | 32 | 51 | 64 | 27 | 25 | 21 |
| Tax ⓘ | 2 | 9 | 16 | 19 | 9 | 11 | 3 |
| Profit After Tax | 7 | 23 | 36 | 45 | 18 | 14 | 18 |
| PAT Margin (%) | 2.7% | 7.3% | 8.2% | 9.0% | 4.5% | 3.2% | 3.4% |
| Adjusted EPS (₹) | 0.7 | 2.5 | 3.8 | 4.3 | 1.8 | 1.1 | 1.4 |
| Dividend Payout Ratio (%) | 0% | 0% | 7% | 9.20% | 5.70% | 14% | 10.70% |
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 132 | 156 | 190 | 313 | 329 | 682 | 698 | ||||
| Debt + | 39 | 58 | 76 | 45 | 56 | 76 | 222 | ||||
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Trade Payables | 24 | 46 | 55 | 59 | 65 | 93 | 138 | ||||
| Others Liabilities ⓘ | 28 | 13 | 22 | 30 | 127 | 82 | 62 | ||||
| Total Liabilities ⓘ | 224 | 273 | 342 | 447 | 576 | 933 | 1,120 | ||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 138 | 152 | 157 | 173 | 214 | 245 | 580 | ||||
| CWIP ⓘ | 4 | 2 | 5 | 28 | 68 | 289 | 96 | ||||
| Investments ⓘ | 0 | 0 | 0 | 0 | 38 | 0 | 0 | ||||
| Inventories | 56 | 50 | 68 | 91 | 111 | 130 | 146 | ||||
| Trade Receivables | 11 | 60 | 97 | 129 | 107 | 174 | 205 | ||||
| Cash Equivalents | 4 | 1 | 3 | 4 | 11 | 30 | 19 | ||||
| Others Assets ⓘ | 10 | 8 | 13 | 22 | 26 | 66 | 75 | ||||
| Total Assets ⓘ | 224 | 273 | 342 | 447 | 576 | 933 | 1,120 | ||||
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 48 | 4 | 7 | 14 | 34 | -53 | 12 |
| Cash Flow From Investing Activity ⓘ + | -39 | -21 | -17 | -60 | -116 | -201 | -160 |
| Cash Flow From Financing Activity ⓘ + | -9 | 15 | 12 | 46 | 88 | 272 | 136 |
| Net Cash Flow ⓘ | 0 | -2 | 2 | 1 | 7 | 18 | -12 |
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 4.92 | 16.2 | 20.69 | 17.95 | 5.68 | 2.74 | 2.63 | |||
| ROCE (%) | 8.26 | 20.6 | 24.75 | 21.72 | 8.26 | 5.21 | 4.55 | |||
| Asset Turnover Ratio | 1.1 | 1.28 | 1.42 | 1.27 | 0.8 | 0.58 | 0.52 | |||
| PAT to CFO Conversion(x) | 6.86 | 0.17 | 0.19 | 0.31 | 1.89 | -3.79 | 0.67 | |||
| Working Capital Days | ||||||||||
| Receivable Days | 17.10 | 40.90 | 65.50 | 81.90 | 105.60 | 116.40 | 128.90 | |||
| Inventory Days | 83.60 | 61.20 | 49.60 | 57.90 | 90.80 | 99.90 | 93.80 | |||
| Payable Days | 56.10 | 64.80 | 67.40 | 66.90 | 93.50 | 105.90 | 127.50 | |||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Bhagiradha Chemicals & Industries Ltd FAQs
The current trading price of Bhagiradha Chemicals on 25-Sep-2026 16:59 is ₹245.9.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 24-Sep-2026 the market cap of Bhagiradha Chemicals stood at ₹3,189.2 Cr
The latest P/E ratio of Bhagiradha Chemicals as of 24-Sep-2026 is 111.4.
The latest P/B ratio of Bhagiradha Chemicals as of 24-Sep-2026 is 4.34.
The 52-week high of Bhagiradha Chemicals is ₹315.9 and the 52-week low is ₹170.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Bhagiradha Chemicals is ₹571 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Bhagiradha Chemicals & Industries Ltd is a below average quality company.
The key valuation ratios of Bhagiradha Chemicals & Industries Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Bhagiradha Chemicals & Industries Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Bhagiradha Chemicals & Industries Ltd
Bhagiradha Chemicals & Industries (BCIL) incorporated in 1993 is based at Hyderabad, India. The company is into business of manufacturing high quality basic pesticides. It manufacturing unit is located at Ongole, Andhra Pradesh and capacity of 1800 TPA of Chlorpyrifos Technical.
The company enjoys the active participation and support of highly experienced scientists and technocrats and vital linkage to scientific community by its relationship with Indian Institute of Chemical Technology, Hyderabad, a National Laboratory under the council of Scientific and Industrial Research, Government of India.
The company exports 70% of its produce to countries like Australia, South Africa, China, Germany, Singapore, Spain, U.K. Belgium, Greece, Italy, Malaysia, Taiwan, Indonesia, Peru, Brazil, etc.
Product range of the company includes:
- Chlorpyrifos Ethyl Technical 98% min
- High Purity Chlorpyrifos Ethyl Technical 99% min
- Chlorpyrifos Methyl Technical 97% min
- Clodinafop-Propargyl Technical 98% min
- Triclopyr Butoxy Ethyl Ester Technical 98% min
- Formulations such as Chlorpyrifos : 20% E.C, chlorpyrifos : 48% E.C, Chlorpyrifos : 40.8% E.C, Endosulfan : 35% E.C, Fenvalerate : 20% E.C., Ethion : 50% E.C., Dimethoate : 30% E.C., Dichlorvos : 76% E.C., Cypermethrin : 25% E.C., Cypermethrin : 10% E.C, Butachlor : 50% E.C., Alphamethrin : 10% E.C., 2,4-D, Ethyl Ester : 38% E.C., Monocrotophos : 36% S.L., Quinalphos : 25% E.C., Profenofos : 50% E.C. and Imidaclopride.
The company has set up R&D facilities within the factory premises which are equipped to develop processes for generics and to enhance process efficiency of existing operations.
The company has also generated authentic chemical and toxicological data for Chlorpyrifios Ethyl Technical, Chlorpyrifos Methyl Technical, Triclopyr Butoxy Ethyl Ester Technical, and formulations to facilitate registration of these products in the importing countries.
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
